INR 28755.5
(2.3%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 12.01 Billion INR | 26.52% |
2022 | 9.49 Billion INR | 18.87% |
2021 | 7.98 Billion INR | 15.64% |
2020 | 6.9 Billion INR | 16.49% |
2019 | 5.92 Billion INR | 31.67% |
2018 | 4.5 Billion INR | 12.24% |
2017 | 4.01 Billion INR | 45.03% |
2016 | 2.76 Billion INR | 6.56% |
2015 | 2.59 Billion INR | 13.39% |
2014 | 2.28 Billion INR | 37.31% |
2013 | 1.66 Billion INR | 15.24% |
2012 | 1.44 Billion INR | 20.19% |
2011 | 1.2 Billion INR | 97.58% |
2010 | 609.35 Million INR | -21.38% |
2009 | 775.1 Million INR | 23.29% |
2008 | 628.7 Million INR | -8.13% |
2007 | 684.3 Million INR | 14.32% |
2006 | 598.6 Million INR | 1.17% |
2005 | 591.7 Million INR | -42.13% |
2004 | 1.02 Billion INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 3.28 Billion INR | 14.27% |
2023 Q1 | 2.9 Billion INR | 25.42% |
2023 FY | 12.01 Billion INR | 26.52% |
2023 Q4 | 2.87 Billion INR | -7.69% |
2023 Q3 | 3.1 Billion INR | -0.63% |
2023 Q2 | 3.12 Billion INR | 7.82% |
2022 FY | 9.49 Billion INR | 18.87% |
2022 Q1 | 2.05 Billion INR | -2.73% |
2022 Q2 | 2.65 Billion INR | 29.12% |
2022 Q3 | 2.46 Billion INR | -7.04% |
2022 Q4 | 2.31 Billion INR | -6.24% |
2021 FY | 7.98 Billion INR | 15.64% |
2021 Q4 | 2.11 Billion INR | 6.13% |
2021 Q3 | 1.99 Billion INR | 3.57% |
2021 Q2 | 1.92 Billion INR | -1.75% |
2021 Q1 | 1.95 Billion INR | 28.39% |
2020 FY | 6.9 Billion INR | 16.49% |
2020 Q3 | 1.77 Billion INR | -1.99% |
2020 Q4 | 1.52 Billion INR | -13.93% |
2020 Q2 | 1.8 Billion INR | 0.21% |
2020 Q1 | 1.8 Billion INR | 62.52% |
2019 Q4 | 1.1 Billion INR | -40.56% |
2019 FY | 5.92 Billion INR | 31.67% |
2019 Q1 | 1.16 Billion INR | 3.31% |
2019 Q2 | 1.78 Billion INR | 52.5% |
2019 Q3 | 1.86 Billion INR | 4.69% |
2018 FY | 4.5 Billion INR | 12.24% |
2018 Q1 | 824 Million INR | -17.67% |
2018 Q3 | 1.17 Billion INR | -14.98% |
2018 Q2 | 1.37 Billion INR | 67.09% |
2018 Q4 | 1.13 Billion INR | -3.3% |
2017 FY | 4.01 Billion INR | 45.03% |
2017 Q2 | 1.37 Billion INR | 185.02% |
2017 Q4 | 1 Billion INR | -13.27% |
2017 Q3 | 1.15 Billion INR | -16.09% |
2017 Q1 | 482.5 Million INR | 14.72% |
2016 Q2 | 750.2 Million INR | 1.36% |
2016 FY | 2.76 Billion INR | 6.56% |
2016 Q3 | 855.6 Million INR | 14.05% |
2016 Q1 | 740.1 Million INR | 25.46% |
2016 Q4 | 420.6 Million INR | -50.84% |
2015 Q1 | 685.6 Million INR | 37.78% |
2015 FY | 2.59 Billion INR | 13.39% |
2015 Q3 | 703.6 Million INR | 14.04% |
2015 Q4 | 589.9 Million INR | -16.16% |
2015 Q2 | 617 Million INR | -10.01% |
2014 Q3 | 645.3 Million INR | 1.24% |
2014 FY | 2.28 Billion INR | 37.31% |
2014 Q2 | 637.4 Million INR | 25.15% |
2014 Q1 | 509.3 Million INR | 32.66% |
2014 Q4 | 497.59 Million INR | -22.89% |
2013 Q2 | 451.9 Million INR | 52.1% |
2013 Q3 | 534.6 Million INR | 18.3% |
2013 Q4 | 383.9 Million INR | -28.19% |
2013 FY | 1.66 Billion INR | 15.24% |
2013 Q1 | 297.1 Million INR | -6.28% |
2012 Q3 | 497.7 Million INR | 29.85% |
2012 Q1 | 295.2 Million INR | 9.01% |
2012 Q2 | 383.3 Million INR | 29.84% |
2012 Q4 | 317 Million INR | -36.31% |
2012 FY | 1.44 Billion INR | 20.19% |
2011 Q3 | 368.83 Million INR | -15.46% |
2011 Q4 | 270.8 Million INR | -26.58% |
2011 Q2 | 436.3 Million INR | 0.0% |
2011 FY | 1.2 Billion INR | 97.58% |
2010 FY | 609.35 Million INR | -21.38% |
2009 FY | 775.1 Million INR | 23.29% |
2008 FY | 628.7 Million INR | -8.13% |
2007 FY | 684.3 Million INR | 14.32% |
2006 FY | 598.6 Million INR | 1.17% |
2005 FY | 591.7 Million INR | -42.13% |
2004 FY | 1.02 Billion INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Cipla Limited | 41.21 Billion INR | 70.855% |
Gland Pharma Limited | 7.72 Billion INR | -55.506% |
GlaxoSmithKline Pharmaceuticals Limited | 5.89 Billion INR | -103.61% |
Kopran Limited | 509.56 Million INR | -2257.363% |
Marksans Pharma Limited | 3.13 Billion INR | -282.92% |
NGL Fine-Chem Limited | 413.16 Million INR | -2807.347% |
Pfizer Limited | 5.51 Billion INR | -117.877% |
Sanofi India Limited | 6.02 Billion INR | -99.24% |
SMS Pharmaceuticals Limited | 498.26 Million INR | -2310.83% |
TTK Healthcare Limited | 628.41 Million INR | -1811.495% |